Consistent with our data, AXL expression diminished STAT1 phosphorylation and MHC class I expression in a mouse mammary tumor model46 and induced mesenchymal transition via TGFß/SNAI1-signaling, leading to the downregulation of MHC class I expression in prostate cancer47. Here, AXL is linked to breast cancer.